Found 94 matching trials
Phase 2a, AMP Challenge, Dose Escalation Study to Assess the Dose Response for Topical Efficacy and Systemic Activity in Asthmatic Subjects PHASE2 This is a randomized, placebo-controlled, 2-period crossover, escalating re...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Dose-Finding Study Evaluating Safety and Efficacy in Patients With Chronic Obstructive Pulmonary Disease PHASE2 The purpose of the study is to determine the appropriate dose of fluticason...
Show More Learn More & Join Trial
Airway Microbiome in Asthma: Relationships to Asthma Phenotype and Inhaled Corticosteroid Treatment NA There are new, very sensitive methods for detecting bacteria. These methods...
Show More Location
University of California, San Francisco, Adult
Learn More & Join Trial
Chronic Obstructive Pulmonary Disease (COPD) Post-hospitalization Study PHASE4 This trial is a randomized, double-blind, parallel-group, multicenter study...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Bioequivalence Study of Synflutide HFA Inhaler and Seretide Evohaler in Healthy Volunteers With Charcoal Block PHASE1 The objective of this pivotal study is to evaluate the relative bioavailabi...
Show More Location
Clinical Pharmacology Unit of Mackay Memorial Hospital Tamshui Branch
Learn More & Join Trial
Pharmacokinetic Study in Healthy Volunteers to Characterise the Exposure of Fluticasone Furoate (FF), Vilanterol (VI) and Umeclidinium (UMEC) at Two Different Doses PHASE1 This study will evaluate the pharmacokinetics of FF, UMEC and VI administer...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Study of FlutiForm® Versus Fluticasone Plus Formoterol in Adult Subjects With Severe Asthma PHASE3 The study compares the efficacy and safety of FlutiForm® vs Flixotide® plus...
Show More Location
Multiple Locations
Learn More & Join Trial
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma PHASE4 The purpose of this study is to evaluate the site and mechanisms responsibl...
Show More Location
Arthur F Gelb Medical Corporation
Learn More & Join Trial
A Phase III Parallel Group Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination (FDC) of Fluticasone Furoate+Umeclidinium Bromide+Vilanterol (FF/UMEC/VI) With the FDC of FF/VI in Subjects With Inadequately Controlled Asthma PHASE3 A once-daily 'closed' triple FDC therapy of FF/UMEC/VI via a single ELLIPTA...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Comparative Study on Usability of Inhaler Devices in Adults With Asthma or COPD NA This is a randomized, multi-center, active-controlled, repeated measures de...
Show More Location
3) Fondazione S. Maugeri - IRCCS - Dipartimento di Pneumologia Riabilitativa
Learn More & Join Trial